Company Profile
Ulisse BioMed S.p.A. is a biotechnology company specialized in developing medical diagnostics, theranostics and therapeutics solutions. The company has 3 technology platforms, namely, Sagitta (molecular diagnostics), NanoHybrid (theranostics and diagnostics) and Aptavir (therapeutics).
Italy accounts for all net sales.
Italy accounts for all net sales.
Source: Cofisem - Last Update: 2025-02-06
Key Executives
| Chief Executive Officer | |
| Head of Investor Relations |
Source: Cofisem - Last Update: 2025-02-06
Key Figures
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 66 | 138 | 277 | 429 | 11 |
| Consumed purchases | 316 | 328 | 117 | 141 | 116 |
| Labour costs | 497 | 330 | 141 | 111 | 524 |
| Operating profit | -4,796 | -1,306 | -604 | 224 | -1,116 |
| Income tax | 0 | 0 | 0 | 2 | -18 |
| Net income | -4,796 | -1,308 | -604 | 222 | -1,098 |
| Net income (Group share) | -4,797 | -1,308 | -604 | 222 | -1,098 |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | Local GAAP | Local GAAP | Local GAAP | Local GAAP | Local GAAP |
Source: Cofisem - Last Update: 2025-02-06
Shareholder information
| Free float | |
| Other shareholders | |
| Stefano Lo Priore | |
| Alberto Amati | |
| Algebris Investments Limited | |
| Good Harvest Ventures | |
| Locorian s.s. | |
| Copernico Innovazione S.r.l. | |
| Bantess s.s. | |
| Bruna Marini | |
| Matteo Petti |
Source: Cofisem - Last Update: 2025-02-06
Address
Ulisse BioMed S.p.A.
Via Aquileia 17
IT-33100 Udine
Italy
Phone number: +39 040 3757540
https://ulissebiomed.com
Source: Cofisem - Last Update: 2025-02-06
Contact
Please contact MyQuestion.Italy@euronext.com for Company Profile support.
